Prenatal intake of magnesium may harm fetal bones, FDA warns

05/31/2013 |

Clinicians should not give pregnant women magnesium sulfate for more than five to seven days due to reports claiming reduced calcium levels and bone abnormalities in babies, the FDA warned on Thursday. Off-label uses of the drug include the prevention of preterm labor as well as seizures during pregnancy, but officials said the labeling would be changed to emphasize that the medication is not indicated for preventing preterm labor.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN